We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Etanercept in severe active rheumatoid arthritis: first Australian experience.
- Authors
Perera, L C; Tymms, K E; Wilson, B J; Shadbolt, B; Brook, A S; Dorai Raj, A K; Khoo, K B K
- Abstract
Etanercept reduces disease activity in adults with chronic rheumatoid arthritis (RA) who are resistant to other therapies. Medicare Australia Pharmaceutical Benefit Scheme subsidized treatment (since August 2003) restricts etanercept availability to a most drug-resistant RA population. The aim of the study was to assess the efficacy of etanercept in this unique group after 12 months of therapy.
- Publication
Internal medicine journal, 2006, Vol 36, Issue 10, p625
- ISSN
1445-5994
- Publication type
Journal Article
- DOI
10.1111/j.1445-5994.2006.01170.x